StockStory.org on MSN15d
Privia Health (NASDAQ:PRVA) Surprises With Q4 Sales But Full-Year Sales Guidance Misses Expectations
Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced in Q4 CY2024, with sales up 4.6% year on year to $460.9 ...
Privia Health price target raised to $40 from $25 at Piper Sandler
Piper Sandler raised the firm’s price target on Privia Health (PRVA) to $40 from $25 and keeps an Overweight rating on the shares. In the ...
Privia Health price target raised to $29 from $26 at Citizens JMP
Citizens JMP raised the firm’s price target on Privia Health (PRVA) to $29 from $26 and keeps an Outperform rating on the shares. Privia ...